We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

128 hedge funds and large institutions have $62.9M invested in SANGAMO THERAPEUTICS INC in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 16

30% more capital invested

Capital invested by funds: $48.4M → $62.9M (+$14.5M)

24% more funds holding

Funds holding: 103 → 128 (+25)

14% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 29

2.65% more ownership

Funds ownership: 26.86% → 29.51% (+2.7%)

44% less call options, than puts

Call options by funds: $1.87M | Put options by funds: $3.35M

Holders
128
Holders Change
+25
Holders Change %
+24.27%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
33
Reduced
29
Closed
16
Calls
$1.87M
Puts
$3.35M
Net Calls
-$1.49M
Net Calls Change
-$466K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$7.96M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.15M
3
IC
Ikarian Capital
Texas
+$3.4M
4
SSA
Schonfeld Strategic Advisors
New York
+$3.13M
5
BlackRock
BlackRock
New York
+$2.86M

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$18.7M
2
Marshall Wace
Marshall Wace
United Kingdom
-$3.69M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.23M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.33M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$748K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$9.56M -$408K -223,049 -2%
WA
2
Wasatch Advisors
Utah
$9.42M -$18.7M -10,210,863 -53%
BlackRock
3
BlackRock
New York
$5.3M +$2.86M +1,564,235 +43%
State Street
4
State Street
Massachusetts
$5.12M +$7.96M +4,354,414 +655%
Renaissance Technologies
5
Renaissance Technologies
New York
$3.15M -$3.23M -1,767,900 -36%
Millennium Management
6
Millennium Management
New York
$2.79M +$1.51M +828,337 +43%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$2.32M +$4.15M +2,270,550 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$2.26M +$134K +73,540 +3%
Morgan Stanley
9
Morgan Stanley
New York
$1.92M +$2.79M +1,528,514 +433%
IC
10
Ikarian Capital
Texas
$1.9M +$3.4M +1,860,179 New
SSA
11
Schonfeld Strategic Advisors
New York
$1.74M +$3.13M +1,709,615 New
Goldman Sachs
12
Goldman Sachs
New York
$1.64M +$2.81M +1,538,428 +2,247%
Charles Schwab
13
Charles Schwab
California
$1.16M +$65.7K +35,926 +3%
Two Sigma Investments
14
Two Sigma Investments
New York
$1.03M +$1.28M +698,296 +222%
Citadel Advisors
15
Citadel Advisors
Florida
$820K +$141K +77,257 +11%
HighTower Advisors
16
HighTower Advisors
Illinois
$772K -$66.3K -36,255 -5%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$757K -$1.33M -729,255 -50%
ACP
18
Acuta Capital Partners
California
$755K +$1.35M +740,000 New
Squarepoint
19
Squarepoint
New York
$725K +$1.3M +710,363 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$722K +$1.29M +707,555 New
Fidelity Investments
21
Fidelity Investments
Massachusetts
$590K +$62.6K +34,262 +6%
BFM
22
Boothbay Fund Management
New York
$548K +$982K +537,219 New
CSS
23
Cubist Systematic Strategies
Connecticut
$466K +$835K +456,946 New
Macquarie Group
24
Macquarie Group
Australia
$408K – – –
Northern Trust
25
Northern Trust
Illinois
$406K +$31.2K +17,049 +4%
1
2 3 4 5

SGMO Hedge Fund Activity: Q4 2024 in Review

128 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2024, worth a combined $62.9M — up 30% from $48.4M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new SGMO positions and 16 closed out — a net gain of 26 holders — while 33 added to existing stakes and 29 trimmed.

The largest buyer was State Street, adding an estimated $7.96M. The largest seller was Wasatch Advisors, cutting an estimated $18.7M.

  • 128 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2024, up from 103 in Q3 2024.
  • Funds reported $62.9M of SANGAMO THERAPEUTICS INC stock for Q4 2024, up 30% quarter-over-quarter.
  • 42 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2024 and 16 closed out, a net change of +26 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2024 was State Street, an estimated $7.96M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2024 was Wasatch Advisors, an estimated $18.7M sold.

Based on aggregated 13F filings for Q4 2024.